India's GlaxoSmithKline Pharma jumps on Q4 profit rise
14/05/2025 04:55
** Shares of India's GlaxoSmithKline Pharma GLAX.NS rise nearly 8% to 3,006 rupees in early trade ** Drugmaker reports 35% rise in Q4 consolidated profit; revenue up 5% ** Stock up about 24% YTD (Reporting by Hritam Mukherjee in Bengaluru) ((Hritam.Mukherjee@thomsonreuters.com;))
Recent news on GlaxoSmithKline Pharmaceuticals
See all newsGSK India first-quarter profit rises on steady vaccine demand
Brief: Glaxosmithkline Pharma Q1 Consol Profit 2.37 Billion Rupees
Brief: Glaxosmithkline Pharmaceuticals: Receives Demand Notice From National Pharmaceutical Pricing Authority
India's GlaxoSmithKline Pharma gains after Q4 profit rise; PT hike
Brief: Glaxosmithkline Pharmaceuticals March-Quarter Consol Profit 2.78 Billion Rupees